Wound debridement is the process of removing dead tissue from wounds. Biological debridement, enzymatic debridement, autolytic debridement, and mechanical debridement are some of the types of wound debridement. Hydrotherapy, wet-to-dry dressing, and monofilament debridement pads are the types of mechanical debridement. Wound debridement products are used in the treatment and management of chronic ulcers, surgical wounds, traumatic wounds, and burns. Wound debridement aids in the removal of necrotic tissue and bacteria and senescent cells. Debridement agents may cause side effects, such as skin irritation, which can manifest as pain, erythema, as well as a burning, itching, or a tingling sensation, as there are no contraindications for the use of debridement agents. Wound debridement involves removal of dead, infected, or damaged tissue to accelerate healing process of the remaining healthy tissue. Removal of dead tissue on a regular basis accelerates the growth of new tissues, reduces the risk of infection that leads to faster healing process. There are several devices available in the market for wound debridement such as mechanical pads, Hydrosurgical Debridement Devices, Low Frequency Ultrasound Devices, Traditional Wound Debridement Devices, and others.
Market Dynamics
Increasing adoption of organic strategies such as acquisition by key market players is expected to drive the global wound debridement products market growth over the forecast period. For instance, in October 2021, Bioventus, a medical device company, announced that it had acquired Misonix, Inc., a manufacturer of ultrasonic surgical device, to increase the adoption of the recently launched neXus platform that is used to facilitate ultrasonic procedures across spinal decompressions by using the BoneScalpel, and SonicOne for tissue debridement in chronic wounds.
Key features of the study:
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook